| Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus SA Hasni, S Gupta, M Davis, E Poncio, Y Temesgen-Oyelakin, ... Nature communications 12 (1), 3391, 2021 | 120 | 2021 |
| Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study V Giudice, P Pagliano, A Vatrella, A Masullo, S Poto, BM Polverino, ... Frontiers in pharmacology 11, 857, 2020 | 115 | 2020 |
| The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF A D'Addio, A Curti, N Worel, K Douglas, MR Motta, S Rizzi, E Dan, S Taioli, ... Bone marrow transplantation 46 (3), 356-363, 2011 | 109 | 2011 |
| Deep sequencing and flow cytometric characterization of expanded effector memory CD8+ CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in … V Giudice, X Feng, Z Lin, W Hu, F Zhang, W Qiao, MPF Ibanez, O Rios, ... Haematologica 103 (5), 759, 2018 | 77 | 2018 |
| Stem cell mobilization and collection in patients with liver cirrhosis S Lorenzini, A Isidori, L Catani, A Gramenzi, S Talarico, F Bonifazi, ... Alimentary pharmacology & therapeutics 27 (10), 932-939, 2008 | 76 | 2008 |
| Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells F Orio, G Muscogiuri, S Palomba, B Serio, M Sessa, V Giudice, I Ferrara, ... The Scientific World Journal 2014, 2014 | 72 | 2014 |
| Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer N Montuori, A Pesapane, FW Rossi, V Giudice, A De Paulis, C Selleri, ... Translational Medicine@ UniSa 15, 15, 2016 | 64 | 2016 |
| Short-and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study C Tassi, PL Tazzari, F Bonifazi, V Giudice, A Nannetti, F Ricci, S Rizzi, ... Bone Marrow Transplantation 36 (4), 289-294, 2005 | 58 | 2005 |
| Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome A Vicente, BA Patel, F Gutierrez-Rodrigues, EM Groarke, V Giudice, ... Haematologica 105 (12), 2785, 2020 | 51 | 2020 |
| Reproductive issues in patients undergoing hematopoietic stem cell transplantation: an update M Guida, MA Castaldi, R Rosamilio, V Giudice, F Orio, C Selleri Journal of ovarian research 9, 1-8, 2016 | 39 | 2016 |
| Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes V Giudice, LG Banaszak, F Gutierrez-Rodrigues, S Kajigaya, R Panjwani, ... Haematologica 103 (7), 1150, 2018 | 38 | 2018 |
| Aplastic anemia: pathophysiology V Giudice, C Selleri Seminars in Hematology 59 (1), 13-20, 2022 | 36 | 2022 |
| Chondrogenic commitment of human bone marrow mesenchymal stem cells in a perfused collagen hydrogel functionalized with hTGF-β1-releasing PLGA microcarrier EP Lamparelli, J Lovecchio, MC Ciardulli, V Giudice, TP Dale, C Selleri, ... Pharmaceutics 13 (3), 399, 2021 | 36 | 2021 |
| Cardiotoxicity of novel targeted hematological therapies V Giudice, C Vecchione, C Selleri Life 10 (12), 344, 2020 | 33 | 2020 |
| Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes V Giudice, Z Wu, S Kajigaya, MPF Ibanez, O Rios, F Cheung, S Ito, ... Cytokine 113, 462-465, 2019 | 33 | 2019 |
| Stem cell and macrophage roles in skeletal muscle regenerative medicine P Scala, L Rehak, V Giudice, E Ciaglia, AA Puca, C Selleri, G Della Porta, ... International Journal of Molecular Sciences 22 (19), 10867, 2021 | 31 | 2021 |
| Immunological derangement in hypocellular myelodysplastic syndromes B Serio, AM Risitano, V Giudice, N Montuori, C Selleri Translational Medicine@ Unisa 8, 31, 2014 | 31 | 2014 |
| Single-cell RNA sequencing coupled to TCR profiling of large granular lymphocyte leukemia T cells S Gao, Z Wu, B Arnold, C Diamond, S Batchu, V Giudice, L Alemu, ... Nature Communications 13 (1), 1982, 2022 | 30 | 2022 |
| Aptamers and antisense oligonucleotides for diagnosis and treatment of hematological diseases V Giudice, F Mensitieri, V Izzo, A Filippelli, C Selleri International journal of molecular sciences 21 (9), 3252, 2020 | 28 | 2020 |
| OPSI threat in hematological patients B Serio, L Pezzullo, V Giudice, R Fontana, S Annunziata, I Ferrara, ... Translational Medicine@ UniSa 6, 2, 2013 | 28 | 2013 |
Carmine SELLERIUniversità di Salerno, Dipartmento di MedicinaVerified email at unisa.it
